Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
15
Number of overlapping holdings
30.0%
% of FTXH's 51 holdings also in XPH
37.5%
% of XPH's 40 holdings also in FTXH
Overlap by Weight
Sector Drift (FTXH minus XPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
JOHNSON & JOHNSON | 8.1% | 4.1% | 4.1% |
|
ELI LILLY & CO | 3.9% | 4.3% | 3.9% |
|
ZOETIS INC | 3.8% | 3.9% | 3.8% |
|
PFIZER INC | 7.1% | 3.7% | 3.7% |
|
MERCK & CO. INC. | 7.1% | 3.6% | 3.6% |
Position Highlights (Non-Overlapping Exposures)
FTXH Overweight Relative to XPH
|
ABBVIE INC | 7.0% |
|
JOHNSON & JOHNSON | 4.0% |
|
GILEAD SCIENCES INC | 3.9% |
|
AMGEN INC | 3.8% |
|
UNITED THERAPEUTICS CORP | 3.8% |
|
MERCK & CO. INC. | 3.6% |
|
BIOGEN IDEC INC | 3.6% |
|
BRISTOL-MYERS SQUIBB CO | 3.5% |
|
PFIZER INC | 3.4% |
|
REGENERON PHARMACEUTICALS | 3.4% |
FTXH Underweight Relative to XPH
|
TARSUS PHARMACEUTICALS, INC. | -4.2% |
|
ROYALTY PHARMA PLC CLASS A | -4.2% |
|
CORCEPT THERAPEUTICS INC | -4.2% |
|
PACIRA PHARMACEUTICALS INC | -3.2% |
|
AXSOME THERAPEUTICS, INC. | -3.2% |
|
PRESTIGE BRANDS HOLDINGS INC | -3.1% |
 |
PERRIGO CO | -2.9% |
|
ARVINAS, INC. | -2.8% |
|
HARMONY BIOSCIENCES HOLDINGS, INC. | -2.8% |
|
AMPHASTAR PHARMACEUTICALS INC | -2.5% |